Mr. Speaker, the member made reference to commercialization. I would like to just note for him section 7.3 of the proposed guidelines of the Canadian Institutes of Health Research, which states:
Researchers or their institutions with financial interests in the outcome of the stem cell research must disclose this information to the...Oversight Committee, the REB and the prospective research participants [the donors].
It also goes on to say that may not be enough and that:
copies of contracts between researchers, institutions, industry sponsors and any relevant budgetary information must be provided to the...Oversight Committee and the local REB [research ethics board]--
Obviously it is contemplated that there would be commercialization, money changing hands and big business after the donation is made, but the bill specifically prohibits any exchange of money between the donor and any other party. Why is that? Maybe the member could give us an idea of why it is that the donors have to sign off to say that they would not benefit from making their donation whereas others can make money.